Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.86
0.010.54%
At close: Dec 11, 4:00 PM EST
$1.86
N/A
Pre-Market: 7:06 AM EST
Comments
Loading...
Innate Pharma (IPHA) Stock Price, Quote, News & History
IPHANASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Innate Pharma (IPHA) stock?
You can purchase shares of Innate Pharma (NASDAQ:IPHA) through any online brokerage.
Who are Innate Pharma (IPHA) competitors?
Other companies in Innate Pharma’s space includes: Molecular Partners AG (NASDAQ:MOLN), Kalaris Therapeutics Inc (NASDAQ:KLRS), Burning Rock Biotech Ltd (NASDAQ:BNR), Armata Pharmaceuticals Inc (AMEX:ARMP) and Vistagen Therapeutics Inc (NASDAQ:VTGN).
What is the forecast, or price target, for Innate Pharma (IPHA) stock?
Innate Pharma has a consensus price target of $5.00.
What is the current price for Innate Pharma (IPHA)?
The stock price for Innate Pharma (NASDAQ: IPHA) is $1.86 last updated December 12, 2025 at 8:09 AM EST.
Does Innate Pharma (IPHA) pay a dividend?
There are no upcoming dividends for Innate Pharma.
When is Innate Pharma (NASDAQ:IPHA) reporting earnings?
Innate Pharma does not have any upcoming earnings scheduled.
Is Innate Pharma (IPHA) going to split?
There is no upcoming split for Innate Pharma.
What sector and industry does Innate Pharma (IPHA) operate in?
Innate Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
